ÂÜÀòÂÒÂ×

Jennifer Millian has a diverse work experience spanning multiple positions and companies. Jennifer most recently served as Vice President of US Operations at Adrestia Therapeutics starting in September 2022. Prior to that, Jennifer held various roles at Affinia Therapeutics from 2020 to 2022, including Vice President of Program and Alliance Management where they oversaw the MLD and BMBC preclinical programs, research platform, and program management department. Jennifer also worked closely with the executive leadership team to establish corporate and R&D strategies.

Before Affinia Therapeutics, Jennifer worked at uniQure as Director of Program Management from 2018 to 2020, leading the Hemophilia B and Huntington programs. Jennifer facilitated program and R&D team meetings and provided strategic leadership.

Jennifer also has experience at Sanofi Genzyme, where they served as Director and Global Project Manager in 2018, overseeing program strategy and driving cross-functional teams. Jennifer was previously an Associate Director and Project Manager in the Rare Disease department, managing clinical trials and study timelines. Earlier in their career, they held roles as Senior Program Manager, Senior Project Manager, Principal Research Associate, Senior Research Associate, Research Associate, and Quality Control Analyst in various companies.

Overall, Jennifer Millian has demonstrated strong leadership and program management skills, as well as experience in research, development, and quality control within the biotechnology industry.

Jennifer Millian has a strong educational background with a focus on business administration, biotechnology, and environmental science. Jennifer obtained a Master of Business Administration (M.B.A.) degree from Nichols College between 2010 and 2014. Prior to that, they earned a Master of Science (M.S.) degree in Biotechnology from Worcester State University from 2003 to 2005. Jennifer also holds a Bachelor of Applied Science (B.A.Sc.) degree in Environmental Science from Assumption University, which they completed from 1998 to 2002.

In addition to their formal education, Jennifer Millian has obtained a certification from Sanofi's Lean Academy One (LA1), although the specific details such as the month and year of acquisition are not provided.